During the past decade, Jyväskylä Central Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jyväskylä Central Hospital" #1 sponsor was "University of Oulu" with 3 trials, followed by "Jyväskylä Central Hospital" with 2 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Central Finland Hospital District" with 1 trials sponsored and "Chembrain LTD" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jyväskylä Central Hospital" #1 collaborator was "Jyväskylä Central Hospital" with 2 trials as a collaborator, "Satakunta Central Hospital" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Apollo Hospital, New Delhi, India" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Jyväskylä Central Hospital" are "Acute Coronary Syndrome" (1 trials), "Bladder Cancer" (1 trials), "Cholecystolithiasis" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Distal Radius Fracture" (1 trials). Many other conditions were trialed in "Jyväskylä Central Hospital" in a lesser frequency.

Most popular intervention types in "Jyväskylä Central Hospital" are "Drug" (4 trials), "Device" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Parietene Macro" (2 trials), "BCG instillation therapy" (1 trials), "Bendamustine" (1 trials), "Betamethasone sodium phos (drug)" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jyväskylä Central Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Jyväskylä Central Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jyväskylä Central Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Jyväskylä Central Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".